ArticleCureus2025
Perforated Jejunal Gastrointestinal Stromal Tumor in a Young Male Patient With Acute Peritonitis: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perforated jejunal GIST after blunt abdominal trauma: a case report.Journal of surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms of the gastrointestinal (GI) tract, typically diagnosed in older adults. Jejunal GISTs with spontaneous perforation leading to acute peritonitis are uncommon, particularly in young individuals. We report the case of a 32-year-old male who presented with acute abdominal pain, vomiting, and peritoneal signs. Contrast-enhanced computed tomography (CT) revealed pneumoperitoneum and a heterogeneously enhancing mass at the jejunoileal junction, raising suspicion for a perforated GIST. Emergency exploratory laparotomy confirmed a 6 × 6 cm perforated tumor on the antimesenteric border of the jejunum, which was resected with primary anastomosis. Histopathology confirmed a high-grade spindle-cell GIST with increased mitotic activity. The patient recovered well postoperatively and started on adjuvant imatinib therapy following oncological consultation. A four-week post-discharge positron emission tomography-CT (PET-CT) scan showed no residual disease or metastasis. Perforated jejunal GISTs are rare and carry a high risk of recurrence and poor prognosis if not promptly managed. Surgical resection remains the cornerstone of treatment, with adjuvant tyrosine kinase inhibitor therapy recommended for high-risk cases. Given the aggressive nature of perforated GISTs, long-term surveillance is essential. This case highlights the importance of early diagnosis and prompt surgical intervention in perforated jejunal GISTs, particularly in younger patients. Multidisciplinary management with adjuvant therapy and rigorous follow-up is crucial to optimizing outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.